Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Giulia Palermo, Angelo Spinello, Aakash Saha & Alessandra Magistrato. (2021) Frontiers of metal-coordinating drug design. Expert Opinion on Drug Discovery 16:5, pages 497-511.
Read now
Read now
Articles from other publishers (11)
Jameel Ahmed Bhutto, Zhonglin He, Jawayria Najeeb, Sumaira Naeem, Eman A. Mahmoud & Hosam O. Elansary. (2024) Data driven analysis of aromatase inhibitors through machine learning, database mining and library generation. Chemical Physics 577, pages 112143.
Crossref
Crossref
Opeyemi Iwaloye, Paul Olamide Ottu, Femi Olawale, Olorunfemi Oyewole Babalola, Olusola Olalekan Elekofehinti, Babatomiwa Kikiowo, Abayomi Emmanuel Adegboyega, Henry Nnaemeka Ogbonna, Covenant Femi Adeboboye, Ibukun Mary Folorunso, Aderonke Elizabeth Fakayode, Moses Orimoloye Akinjiyan, Sunday Amos Onikanni & Sergey Shityakov. (2023) Computer-aided drug design in anti-cancer drug discovery: What have we learnt and what is the way forward?. Informatics in Medicine Unlocked 41, pages 101332.
Crossref
Crossref
Anjleena Malhotra, Ranjit Singh, Pratap Chandra Acharya & Ranju Bansal. 2023. Medicinal Chemistry of Chemotherapeutic Agents. Medicinal Chemistry of Chemotherapeutic Agents
589
613
.
Jessica Caciolla, Silvia Martini, Angelo Spinello, Federica Belluti, Alessandra Bisi, Nadia Zaffaroni, Alessandra Magistrato & Silvia Gobbi. (2022) Single-digit nanomolar inhibitors lock the aromatase active site via a dualsteric targeting strategy. European Journal of Medicinal Chemistry 244, pages 114802.
Crossref
Crossref
Angelo Spinello, Jure Borišek, Matic Pavlin, Pavel Janoš & Alessandra Magistrato. (2021) Computing Metal‐Binding Proteins for Therapeutic Benefit. ChemMedChem 16:13, pages 2034-2049.
Crossref
Crossref
Gloria Ana, Patrick M. Kelly, Azizah M. Malebari, Sara Noorani, Seema M. Nathwani, Brendan Twamley, Darren Fayne, Niamh M. O’Boyle, Daniela M. Zisterer, Elisangela Flavia Pimentel, Denise Coutinho Endringer & Mary J. Meegan. (2021) Synthesis and Biological Evaluation of 1-(Diarylmethyl)-1H-1,2,4-triazoles and 1-(Diarylmethyl)-1H-imidazoles as a Novel Class of Anti-Mitotic Agent for Activity in Breast Cancer. Pharmaceuticals 14:2, pages 169.
Crossref
Crossref
D. V. Sorokin, O. E. Andreeva, E. I. Mikhaevich, Yu. Yu. Shchegolev, A. M. Scherbakov, M. V. Gudkova & M. A. Krasil’nikov. (2020) Effect of the exosome-mediated suppression of the estrogen signaling: the role in the progression of the hormonal resistance of breast cancer cells. Advances in Molecular Oncology 7:3, pages 58-62.
Crossref
Crossref
Eduardo Costa, Tânia Ferreira-Gonçalves, Gonçalo Chasqueira, António S. Cabrita, Isabel V. Figueiredo & Catarina Pinto Reis. (2020) Experimental Models as Refined Translational Tools for Breast Cancer Research. Scientia Pharmaceutica 88:3, pages 32.
Crossref
Crossref
Cristina Ferreira Almeida, Ana Oliveira, Maria João Ramos, Pedro A. Fernandes, Natércia Teixeira & Cristina Amaral. (2020) Estrogen receptor-positive (ER+) breast cancer treatment: Are multi-target compounds the next promising approach?. Biochemical Pharmacology 177, pages 113989.
Crossref
Crossref
Jessica Caciolla, Angelo Spinello, Silvia Martini, Alessandra Bisi, Nadia Zaffaroni, Silvia Gobbi & Alessandra Magistrato. (2020) Targeting Orthosteric and Allosteric Pockets of Aromatase via Dual-Mode Novel Azole Inhibitors. ACS Medicinal Chemistry Letters 11:5, pages 732-739.
Crossref
Crossref
Ida Ritacco, Andrea Saltalamacchia, Angelo Spinello, Emiliano Ippoliti & Alessandra Magistrato. (2020) All-Atom Simulations Disclose How Cytochrome Reductase Reshapes the Substrate Access/Egress Routes of Its Partner CYP450s. The Journal of Physical Chemistry Letters 11:4, pages 1189-1193.
Crossref
Crossref